Opendata, web and dolomites

CTI

A novel, efficient and minimally invasive medical procedure to treat anastomotic leakage during colorectal cancer surgery.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CTI project word cloud

Explore the words cloud of the CTI project. It provides you a very rough idea of what is the project "CTI" about.

99    market    18    boost    tecnoline    trl7    moment    reduce    impacts    anastomotic    transcaecal    round    colorectal    diagnosed    area    prototype    loop    pouches    220    2018    catheter    die    least    successfully    decided    team    modena    plastic    improvements    replace    people    630    roll    italy    anastomoses    population    safer    company    period    energy    it    nowadays    cti    start    patient    surgery    animal    readiness    recovery    preparing    50    hospitals    2014    spain    transport    right    reoccurrence    defunction    ethical    efficient    environmental    91m    rectal    translated    experimental    clinical    hospital    started    hires    disease    founded    surgical    ileostomy    alternative    solution    tests    morbidity    treatment    diminish    worried    technique    leakage    ago    decrease    tumor    connected    97    permits    disposable    invention    despite    invest    ebola    cancer    turnover    2025    launched    1992    stay    complications    medical    positive    feces    risk    committee    time    mortality    rates    passed    innovation    aragon    authorized    patients   

Project "CTI" data sheet

The following table provides information about the project.

Coordinator
TECNOLINE SPA 

Organization address
address: VIA GELATTI 11/A
city: CONCORDIA SULLA SECCHIA
postcode: 41033
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website https://www.tecnolinesrl.org/shop/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECNOLINE SPA IT (CONCORDIA SULLA SECCHIA) coordinator 50˙000.00

Map

 Project objective

It is estimated that in 2018, 97,220 people will be diagnosed with colorectal cancer and that about 50,630 people will die from this disease; making treatment this cancer to be of growing importance nowadays. Despite improvements in the area of surgical treatment of the tumor, there are still many risk factors connected with mortality, recovery and reoccurrence rates, as well as complications (like anastomotic leakage).

After having successfully launched an innovation that permits the transport of Ebola patients in 2014, Tecnoline (a medical company founded in 1992 in Modena, Italy) decided to invest into innovation development for the surgical treatment of colorectal cancer. Three years ago the team started developing a prototype of the Catheter for Transcaecal Ileostomy (CTI), an alternative technique to loop ileostomy to defunction low rectal anastomoses. Our company conducted a positive round of animal and clinical tests.

The new invention is capable to decrease morbidity and mortality rates due to anastomotic leakage and surgery complications; diminish the hospital stay and ‘worried well’ by 50%; reduce the operating time by at least 50% and up to 99% leakage of feces. It also have a positive environmental impact since it replace the disposable plastic pouches and reduce energy use and other impacts connected with the patients stay in the hospitals. Finally, this invention has the potential to boost the company growth, translated into 8.91M€ of turnover (2025) and 40 new hires for the development period.

Tecnoline was authorized by the Ethical Committee of Aragon (Spain) to implement CTI in a patient population in Aragon (18 patients). The solution has just passed through the experimental process and therefore reaches TRL7. Thus, it is the right moment to start preparing the CTI market readiness and roll-out to provide the medical sector with a unique solution that makes treatment of colorectal cancer patients safer, more efficient and effective.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CTI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CTI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

NextGen-O2k (2019)

Next Generation Instrument for In-Depth Analysis of Mitochondrial Fitness

Read More  

Nocturne (2019)

The eye as a window to the brain, extending lifelong brain health

Read More  

polyBioMetal (2019)

Polymer Biotechnological Metallization

Read More